Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-09

Clinical Trial Update: Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee [Phase 2]

View source ↗

Summary

A Phase 2 study of ACP-044 for pain associated with knee osteoarthritis was terminated, and results have been posted (2025-01-09).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACP-044

Snippet

Sponsor: ACADIA Pharmaceuticals Inc. | Conditions: Osteoarthritis Pain | Phase 2 | Status: TERMINATED | Results posted: 2025-01-09